Elixinol Wellness (AU:EXL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Elixinol Wellness Limited has announced a change in the interests of its director, David Fenlon, following a capital consolidation where every 8 securities were consolidated into 1. This move, approved in the recent Extraordinary General Meeting, has adjusted Fenlon’s holdings to 625,294 fully paid ordinary shares and various performance rights and options.
For further insights into AU:EXL stock, check out TipRanks’ Stock Analysis page.